Flotek Industries, Inc. (FTK) Earnings Call Transcript & Summary

November 8, 2023

New York Stock Exchange US Materials Chemicals earnings 24 min

Earnings Call Speaker Segments

Larry Busnardo

executive
#1

Thanks so much, and welcome everyone on this morning's call as we discuss Flotek's results for the third quarter. Here with me today are Ryan Ezell, our Chief Executive Officer, and Bond Clement, our Chief Financial Officer. We'll begin by sharing some prepared comments about the business and how we performed during the quarter. After that, we'll take whatever questions you may have. Our earnings announcement covering the third quarter of 2023 came out yesterday afternoon, and you can find it in the Investor Relations area of Flotek's website. We've also submitted an 8-K along with a refreshed corporate presentation that we'll walk through during this call, and that material will be posted to our site later this morning as well. Beyond that, this call is being webcast, and a replay should be up on our website not long after we finish. I want to remind everyone that anything we say today about projections or what we expect for future events counts as forward-looking statements. Such statements carry a variety of risks and uncertainties, and many of those sit outside our control. These risks and uncertainties could actually — could lead actual outcomes to differ materially from what we currently anticipate and project. We encourage listeners to go over our earnings release and the risk factors described in our SEC filings. Also, please take a look at the reconciliations included in our earnings press release, since non-GAAP financial metrics might come up during this call. With all that said, I'll hand things over to Ryan Ezell. Ryan?

Ryan Ezell

executive
#2

Appreciate that, Larry, and hello everyone. It means a lot to us that so many people follow Flotek and set aside time this morning to go over how we did operationally and financially during 2023's third quarter. The results we posted for Q3 leave me extremely pleased, because we continue to demonstrate real progress in executing our corporate strategy while strengthening the fundamentals of our core business — and nothing illustrates that better than recording our first quarter of positive adjusted EBITDA in five years. Underpinning those results was the considerable financial and operational momentum we've accumulated throughout this year, along with a sizable year-over-year improvement in each of our profitability metrics. At Flotek, we have two distinct business segments that work well together, and the value they deliver is undeniable—they help our customers get the most out of their assets. We'll continue applying our specialized technologies in both chemistry and data analytics to benefit our customers' value chain, while steadily gaining market share and growing margins, which in turn produces a strong return on investment for our shareholders. With that said, let's turn to Slide 8, where I'll review the highlights from our third quarter; Bond will go through those in detail shortly. During Q3, we posted positive adjusted EBITDA, and that marks the ninth quarter in a row of EBITDA improvement. For a third quarter in a row, we got to positive adjusted gross margin, and the margin tied to that came in at 22%. Beyond that, adjusted gross profit for the first 9 months is roughly $20 million higher than what we saw in the same stretch of 2022. Every quarter of 2023 has brought an increase in transactional chemistry revenues, which we owe to a customer base that keeps expanding quickly and to growing uptake of our Prescriptive Chemistry Management business model — that model delivered 128% growth sequentially, while uses of our proprietary complex nano-fluids grew more than 250% year over year. We've shown that our multidisciplinary way of approaching reservoir-centric technologies boosts well productivity when our chemistry applications are used on site, assuming everything else stays the same. For the first nine months of 2023, subscription revenue in our Data Analytics business rose 81% compared with the same period a year earlier. Within that segment, the count of subscription-based services has doubled, which aligns with our strategy of moving toward a data-as-a-service model; those subscription services have posted a 98% annualized retention rate. During the third quarter, 38% of revenue was not attributable to ProFrac. That marks a 58% gain over the first quarter of this year, and we anticipate additional improvement in the fourth quarter. Our liquidity got a boost when we added a $10 million ABL, which was then increased to $13.8 million in October. Our corporate headquarters relocation wrapped up without a hitch, and that gives us $1 million in savings on an annualized basis. On the global side, we opened a new international entity in Abu Dhabi, which should help us grow market share and expand margins as we build up our in-country value-add components, all while bringing our operational cost base down by roughly 30% — that works out to more than $1 million in yearly savings. And last, we shared news that three people from within our team, plus one hire from outside, are stepping into executive leadership positions. First, I'd like to offer my congratulations to Nathan Snoke, who is advancing to Senior Vice President of Global Business Lines; to Shane Wise, who is taking on the position of Senior Vice President of Operations; and to Andrea Berry, who is moving up to Vice President of People Operations, as well as Tom Redlinger, who becomes Vice President of our high-margin Data Analytics segment. These appointments mark the completion of the company's executive leadership team transition, and as a result, we have emerged as an employer of choice across the chemistry and data services landscape. The fresh group brings much deeper know-how on both the technical and operational sides. When you compare that against the overhead spending of the teams we had before, the company comes out ahead by about $0.5 million annually. Such strong outcomes show how much positive, meaningful change we've made in a brief window. And the thing that matters most: every one of those milestones came without a single recordable or lost time incident in operations. My gratitude goes out to all of our employees, whose commitment to safety and to service quality is what made these remarkable results possible. I'm looking forward to us carrying this momentum forward for the remainder of the year. Let me now walk through the quarter in a little more detail. Sequentially, revenue came in a touch lower. That decline stems squarely from the broader cooling we've seen this year in onshore upstream activity. Let me also offer one more point of context. Compared with the third quarter of 2022, the U.S. land rig count has fallen 19%, while total frac fleets are off 12%. Even with that pullback across drilling and completion work overall, Flotek has felt a far smaller effect, thanks to how we've carried out our strategy centered on our differentiated and complementary chemistry and data technologies. Along those lines, revenue from our transactional chemistry operation has risen each quarter during 2024, and during Q3 it climbed another 5%, which has obviously offset the effects of the wider market downturn. On top of that, the chemistry purchasing volumes spelled out in the long-term supply contract with ProFrac were structured to cushion against market swings and give Flotek some protection in preserving economies of scale and stability. Looking at the bigger picture, oil and gas demand should keep growing over the coming ten years, with additional needs extending out to 2045. To sustain output and deliver the extra supply that's required, investments will be needed over the long haul in both short-cycle and long-cycle barrels. With that outlook in mind, we anticipate ongoing need for oilfield services throughout 2024 and afterward. Our expectation is that appetite for the sophisticated chemistry and data offerings we provide will keep growing, opening up fresh chances in additional market verticals — industrial, geothermal, agricultural, solar and hydrogen among them. At this point I'll hand things over to Bond for the important financial details.

J. Clement

executive
#3

Thanks, Ryan. It's wonderful to be here with everyone this morning. To kick things off, I'd like to reinforce Ryan's remarks — all of us are incredibly happy with what we delivered in the third quarter. Our company-wide strategy is generating returns and producing outstanding outcomes, and we hit a number of key milestones over those three months. On Slide 8 in today's presentation, you'll see that we posted a sturdy set of results in every area, with particular strength in the profit measures that compare year over year. We crossed an important threshold by posting positive adjusted EBITDA for the very first time since Q3 of 2018, and that also marked our ninth straight quarter of sequential gains. That's a meaningful accomplishment, and it speaks to how far we've come in getting the most out of Flotek's revenue sources across our varied business segments, along with the ongoing efforts we've undertaken to lower costs throughout the organization. Finally, we bolstered our liquidity position by putting an ABL in place during August, and then we managed to increase its size in October. Turning to the income statement — Slide 9 lays out how total revenues have grown over the past several years, and it also includes the newest guidance range we've given for 2023. Revenue in Q3 came in 4% above the same quarter last year, yet it fell 6% relative to Q2 of 2023. As Ryan noted, that quarter-over-quarter decline stems from the broader slowdown in upstream drilling and completion work. On a brighter note, Flotek's transactional chemistry revenue climbed by nearly 80% versus Q1 of this year. Beyond that, if we take the midpoint of our updated revenue guidance, we'd end up with annual revenue growth of 41% for this year compared with 2022 — a truly remarkable result considering what's happening in the onshore market. Regarding revenue, I'd like to take a moment to go over Flotek's supply agreement with ProFrac. That contract sets minimum thresholds for the chemistry volumes ProFrac must purchase each year. Should those purchases fall short of what the contract requires, we have the right to receive supplemental payments once the measurement period closes — and right now that period spans June 1, 2023 through December 31, 2023. Given how things have gone recently, we don't anticipate that the chemistry purchase thresholds will be satisfied over the measurement period. Because of that, our Q3 and 9-month 2023 revenues factor in anticipated shortfall payments, which gives our profitability a boost. For additional detail on the supply agreement and the changes and amendments made so far, I'd suggest taking a look at the 8-Ks we filed on February 6 of this year, along with May 18, March 10, and February 4 of last year. Now to Slide 10. Gross profit for Q3 rose to $9 million, versus a gross loss of $2 million in the same period of 2022. Adjusted gross profit, which strips out certain noncash costs, came to $10 million, compared with gross profit of just $250,000 in that comparable quarter. Gross profit margin and adjusted gross profit margin both rose during the quarter, reaching 19% and 22%, respectively. Higher third quarter gross profit came mostly from expected shortfall payments tied to the ProFrac supply agreement, along with greater transactional chemistry revenue and ongoing decreases in material and freight costs. For the first 9 months of 2023, adjusted gross profit has risen $19 million against the same period in 2022. Using the midpoints in our updated guidance, we now expect full year 2023 adjusted gross profit to improve by roughly $27 million relative to last year. Turning to Slide 11. Adjusted EBITDA for the third quarter came in at positive $3.3 million. That figure, as the chart shows, marks the ninth straight quarter of gains for this measure. On SG&A, third quarter came to $6.5 million, versus $9.3 million in last year's third quarter, which is a 30% decline year over year, with the gain largely attributable to decreased employee compensation expense and lower legal and professional fees. During October, we resolved the last item of litigation disclosed earlier that had started in 2021. This litigation has cost close to $2 million in the current year, so settling it ought to be highly advantageous as we start directing attention toward 2024 G&A costs. Turning to the bottom line, net income came to $1.3 million for the third quarter, against a net loss of $19 million in the same quarter of 2022. The prior year's third quarter net loss did include a $4 million non-cash loss tied to the fair value change of our convertible notes. On the balance sheet, during August we announced that an asset-based loan had been completed, giving initial credit availability of $10 million. Through pledging of certain real estate assets, we raised that to $13.8 million in October. Roughly $5.4 million of borrowings remain outstanding under the facility, which carries an 11% interest rate, and we presently have about $6.4 million of borrowings available under the ABL, plus approximately $3 million of cash on hand, for total liquidity nearing $10 million. Regarding our 4Q outlook, we have revised full year guidance as follows. Because of the slowdown in onshore activity that Ryan mentioned earlier, total revenues are now projected at $185 million to $200 million, down from the prior estimate of $210 million to $230 million. More significantly, though, adjusted gross profit margin has been raised to a range of 12% to 14%, up from the earlier range of 8% to 10%. Taking the midpoint of the new guidance, that would suggest a 30% gross profit improvement over the previous guidance; that wraps up my remarks. I'll now hand the call back to Ryan for closing comments.

Ryan Ezell

executive
#4

Thank you, Bond. To sum up, Flotek turned in a strong third quarter, since nearly all of our financial measures came in better than they did a year earlier, and we reported positive adjusted EBITDA for the first time in 5 years. We've shown a history of steadily boosting our profitability, yet that progress isn't showing up in the price of our shares. Both the exploration and production side and the oil field service side of the market have been transformed at a fundamental level. Today's marketplace is more consolidated, and it emphasizes returns along with the generation of free cash flow. Customers assign worth to technology and to efficiency, and service companies get rewarded for improving returns and profitability. Within that landscape, Flotek holds a strong position as the collaborative partner of choice for our customers, who now recognize how important it is to maximize production and the rate of return on their assets, which has become central to how they run their operations. That fits perfectly with what our differentiated chemistry and data technologies do best, which is aim at better recovery and getting the most value from our customers' hydrocarbons. This value proposition sets Flotek apart from its peers. Our view is that additional work remains to be done, but we're positioned well to seize the considerable opportunity in front of us as we create value for our shareholders. We're grateful for the ongoing support of all our stakeholders, and we hope you feel the same excitement we do about Flotek's future, and we look forward to sharing more progress. Operator, we're now ready to take questions.

Executive

executive
#5

I'd like to ask about the fleet. Congrats on yet another strong quarter. The results were truly impressive, and the improvement in fee was excellent. I have something I want to ask regarding the fleet and what has been going on with deployments. In what ways have you altered how the fleet itself is deployed, regarding both the quantities and the manner in which you deploy them, in order to boost gross margin?

J. Clement

executive
#6

Hello, Cord — sounds like plenty of input is coming through from your side, but we honestly can't make out what you're asking. Could you say it again for us?

Executive

executive
#7

Alright, I'll begin again. There's a question regarding the fleet and the adjustments you've made to how it's deployed in order to boost gross margin?

Ryan Ezell

executive
#8

Right, so if I've got this right, what you're getting at is where the fleets are actually being sent, and what that's done to our gross margins. Let me offer a few thoughts on that. First, on fleet deployment — sure, the total count was lower, we all know that. What's really driving the big effect, though, is in basins that are rich in gas, like the Haynesville, and we've watched a number of those fleets move into other places — South Texas, West Texas, and so on. When that shift happens, gross margins take a hit from product mix and from where delivery destinations sit, plus how we're able to swap out customers — meaning the white space, or relocating pad sites. What we've observed is a modest hit to revenue overall. In truth, though, the products we're hauling are a lot more efficient for us; freight costs as a share of revenue have come down, and material cost as a share of revenue is back to where it stood before the ProFrac contract — so we've achieved a meaningful gain in our material cost base overall. Hopefully that gives you a bit more color on your question.

Gerry Sweeney

analyst
#9

Morning, Ryan and Bond. I actually had a question along the same lines about gross margins, which I believe Corey just raised. I'd like to dig deeper and grasp not only what's been pushing gross margins, but perhaps a few of the — what will push them going forward involves some of the prescription — prescriptive management, though I think you also mentioned a location regarding where your work sits; so I'm not certain whether we can expand on that. Clearly, I'm somewhat new to the story, but I was simply curious whether we might dig in a bit more.

Ryan Ezell

executive
#10

Yes. So to add to what was said to Corey. When you examine the total operational contribution toward gross margin improvement, much of that has come from our enhancement of our logistical networks and the automization we've implemented there, since we keep seeing freight as a percentage of material costs decline each quarter this year. The second piece contributing to that is the kinds of materials we're moving within the general operations, our material cost as a percentage of revenue are where we stood before we ramped up our ProFrac contract; so as we've been forecasting along our path to profitability there, we're beginning to see those margins come back to the strength we'd want to see. The other major component we're extremely excited about, which has probably had the greatest impact for us, is that our prescriptive chemistry based sales keep rising each quarter. And we call those the transactional business models, and what matters more there is the proprietary technologies we see with our complex nano-Fluids; those have grown 151% on quarter and are up over almost 250% year-on-year; and in Q3, they made up almost 40% of the sales in the transactional business component, which if you return to our best years of profitability back in 2014 and '15, it was at those percentages of revenue. So we keep seeing that evolve, and that's really helping drive our gross margin business. And when you look at it in terms of why that revenues continue to grow, those are 12- to 18-month sales that we've had in place in long-term pursuits on; and as you see, E&P operators look to wanting better performance out of every well drilled; this has become more and more and more important; and that's why I think we're in a really good position to continue to improve our gross margin base.

J. Clement

executive
#11

Hey Gerry, Bond here. Let me jump in with a brief addition. I want to put some context around the figures Ryan mentioned. Our transactional business — what we call the non-ProFrac chemistry segment — generated a bit more than $16 million in revenue during Q3. Back in Q1 of this year, that number stood at $9.2 million.

Gerry Sweeney

analyst
#12

Understood, that helps. And once more, a bit more recent. But Ryan, I believe you had just mentioned a sales cycle of 12 to 18 months. Could you — if that's something you're okay discussing, perhaps just walk through what your present backlog or pipeline looks like, or the number of entities you're speaking with these days, and maybe conversion rates or similar metrics too, if you're able or willing.

Ryan Ezell

executive
#13

Yes. That's an excellent question. When it comes to specifics, I think it adds a fair amount of color, not just regarding how diversified our revenue stack is, but also how strong the pursuits currently in play are. If I were to look back to, let's say, 2021, 2 customers accounted for over 90% of our revenue in that stack. If you look today at our chemistry base transaction, no single customer makes up more than 8%. So we've witnessed considerable diversification in terms of where our revenue originates, and that shift is there. I'd also note that nearly 50% of the revenue that came in during Q3 could be attributed to new customers, which is fantastic. Then, when I look at our pipeline, which begins in Q4 and continues through the close of next year, we've identified almost $400 million in opportunities across our domestic and international business. So we're genuinely excited about what some of those opportunities represent; and again, from my perspective, given these technologies we've brought to the forefront for these E&P operators, along with helping and expanding our relationship with the pressure pumping companies, we're sitting in a really strong position there.

Larry Busnardo

analyst
#14

Appreciate you all taking the time to be with us on today's call once more. We realize it's a hectic morning, given the other calls happening across the industry, so don't hesitate to get in touch with Bond whenever you have further questions. Thanks once more, and enjoy the rest of your day.

Operator

operator
#15

That brings us to the end of this call. We appreciate everyone joining us for today's presentation. You're welcome to hang up at this point.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Flotek Industries, Inc. transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

For developers and AI pipelines

Programmatic access to Flotek Industries, Inc. earnings transcripts and 132,000+ others is available through the EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.

More tools for stock research

OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Flotek Industries, Inc. or any ticker on your watchlist.

StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.